PGEN vs ABSI
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
PGEN · Precigen$4.47 ▲ 5.92%
ABSI · Absci Corp$10.17 ▲ 8.31%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- PGEN +11.8%
- ABSI +206.3%
Head to head
| Metric | PGEN | ABSI |
|---|---|---|
| Price | $4.47 | $10.17 |
| Change today | ▲ 5.92% | ▲ 8.31% |
| Market cap | $1.60B | $1.75B |
| Return, 3 months | -36.1% | +12.9% |
| Return, year to date | +6.9% | +191.4% |
| Return, 1 year | +14.6% | +204.9% |
| P/E (TTM) | 40.6 | – |
| P/B | 19.1 | 7.1 |
| P/E percentile vs own 5y | 11th | 1st |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +6,322.7% | -46.4% |
| Net profit growth (YoY) | +175.3% | -8.6% |
| Gross margin | 90.7% | – |
| Operating margin | -46.1% | -8,411.3% |
| Net margin | -392.8% | -7,756.4% |
| Return on equity | -9,907.5% | -57.7% |
| Analyst target vs. price | +235.6% | +43.2% |
| Analyst buy share | 100% | 90% |
| RSI (14) | 31 | 51 |
| 30-day volatility | 121.4% | 118.8% |
| Max drawdown, 1 year | -50.7% | -48.9% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- ABSI is the largest of the group by market value.
- ABSI has returned the most over the past year.
- PGEN is growing revenue fastest.
- PGEN keeps the most profit per dollar of sales.
- ABSI has been the calmest stock over the last 30 days.